You are here

  • Home
  • Archive
  • Volume 79, Issue 7
  • Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab

Article metrics

Article menu
Download PDFPDF
Rheumatoid arthritis
Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab

 

Online download statistics by month:

Online download statistics by month: May 2020 to November 2023

AbstractFullPdf
May 20201662202121
Jun 20201348228130
Jul 20206879759
Aug 20203565446
Sep 20203815435
Oct 20201973521
Nov 20201581813
Dec 20201451613
Jan 20211021211
Feb 202112455
Mar 2021239117
Apr 202117758
May 20214065
Jun 20211296
Jul 2021110
Aug 202113118
Sep 2021996
Oct 202110389
Nov 202118254
Dec 20218034
Jan 202289118
Feb 202214457
Mar 202210559
Apr 202211549
May 202210744
Jun 202210779
Jul 20228689
Aug 202210765
Sep 2022155176
Oct 20227675
Nov 20227532
Dec 20226065
Jan 20231383711
Feb 202310596
Mar 20238733
Apr 20239623
May 20231824
Jun 20232171210
Jul 20234642
Aug 20234740
Sep 202310110
Oct 20234914
Nov 20238974
Total8235954636